EE200300434A - Farmatseutiliselt toimivate ühendite kasutamine - Google Patents

Farmatseutiliselt toimivate ühendite kasutamine

Info

Publication number
EE200300434A
EE200300434A EEP200300434A EEP200300434A EE200300434A EE 200300434 A EE200300434 A EE 200300434A EE P200300434 A EEP200300434 A EE P200300434A EE P200300434 A EEP200300434 A EE P200300434A EE 200300434 A EE200300434 A EE 200300434A
Authority
EE
Estonia
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
compounds
active
Prior art date
Application number
EEP200300434A
Other languages
English (en)
Inventor
Eek Arne
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx
Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200300434A publication Critical patent/EE200300434A/et
Publication of EE05234B1 publication Critical patent/EE05234B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300434A 2001-03-08 2002-03-05 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks EE05234B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100798A SE0100798D0 (sv) 2001-03-08 2001-03-08 New use
SE0103291A SE0103291D0 (sv) 2001-10-03 2001-10-03 New use
PCT/SE2002/000375 WO2002069968A1 (en) 2001-03-08 2002-03-05 New use

Publications (2)

Publication Number Publication Date
EE200300434A true EE200300434A (et) 2003-12-15
EE05234B1 EE05234B1 (et) 2009-12-15

Family

ID=26655407

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300434A EE05234B1 (et) 2001-03-08 2002-03-05 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks

Country Status (15)

Country Link
US (2) US20040082605A1 (et)
EP (1) EP1370261A2 (et)
JP (1) JP2004520422A (et)
KR (1) KR100904599B1 (et)
CN (1) CN1496259A (et)
BG (1) BG108144A (et)
BR (1) BR0207762A (et)
CA (1) CA2440100A1 (et)
CZ (1) CZ20032398A3 (et)
EE (1) EE05234B1 (et)
IL (1) IL157461A0 (et)
MX (1) MXPA03007888A (et)
NO (1) NO20033919D0 (et)
SK (1) SK10982003A3 (et)
WO (1) WO2002069968A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
ES2297203T3 (es) * 2002-09-19 2008-05-01 Schering Corporation Pirazolopiridinas como inhibidores de quinasas dependientes de ciclina.
DE60317529T2 (de) * 2002-09-19 2008-09-25 Schering Corp. Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
BRPI0407541A (pt) * 2003-02-17 2006-02-14 Altana Pharma Ag combinações e uso de compostos farmaceuticamente ativos selecionados
JPWO2011102460A1 (ja) * 2010-02-19 2013-06-17 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DE69905178T2 (de) * 1998-09-23 2003-07-17 Altana Pharma Ag Tetrahydropyridoether
PT1173439E (pt) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalcoxi imidazonaftiridinas

Also Published As

Publication number Publication date
WO2002069968A8 (en) 2003-04-17
MXPA03007888A (es) 2003-12-04
NO20033919L (no) 2003-09-04
CA2440100A1 (en) 2002-09-12
US20090170854A1 (en) 2009-07-02
KR100904599B1 (ko) 2009-06-25
KR20040007461A (ko) 2004-01-24
SK10982003A3 (sk) 2004-02-03
EP1370261A2 (en) 2003-12-17
WO2002069968A1 (en) 2002-09-12
BR0207762A (pt) 2004-06-01
JP2004520422A (ja) 2004-07-08
NO20033919D0 (no) 2003-09-04
BG108144A (en) 2004-09-30
EE05234B1 (et) 2009-12-15
IL157461A0 (en) 2004-03-28
CZ20032398A3 (cs) 2004-02-18
US20040082605A1 (en) 2004-04-29
CN1496259A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
PT1220856E (pt) Compostos farmaceuticamente activos
CY2009013I2 (el) Νεα χρηση μιας ενωσης πεπτιδικης κατηγοριας για τη θεραπεια του μη νευροπαθους φλεγμονωδους πονου
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20035087D0 (no) Anvendelse av HMG fragment som anti-inflammatoriske midler
NO20033203L (no) Terapeutiske heterocykliske forbindelser
EE200200701A (et) Kõrgkontsentreeritud stabiilsed meloksikaami lahused
NO20033205D0 (no) Terapeutiske kromanforbindelser
DE50213466D1 (de) Fungizide wirkstoffkombinationen
DK1764111T3 (da) Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
DE50209245D1 (de) Neuroprotektives medikament
AR028060A1 (es) Combinaciones de compuestos activos fungicidas
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
NO20041968L (no) Anvendelse av cystationin
GB0105893D0 (en) Pharmaceutically active compounds
GB0107751D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
ID30381A (id) Penggunaan arilalkanoilpiridazina
SE0000645D0 (sv) New pharmaceutically active compounds
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
SE0101239D0 (sv) Pharmaceutically useful compounds
AU2002350212A8 (en) Pharmaceutically active compounds and methods of use thereof
SE9901854D0 (sv) New pharmaceutically active compounds
DE60124221D1 (de) MONOHYDRAT DES CIS-LITHIUM-CYANO-4-i3-(CYCLOPENTYLOY)-4-METHOXYPHENYLöCYCLOHEXANCARBOXYLATS
SE0002921D0 (sv) Pharmaceutically useful compounds

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110305